A single RSV vaccine shot protects adults 60 and older from hospitalization for two seasons. The vaccine reduced the risk of RSV-related hospitalization by 58% over two seasons, according to a new ...
As several European countries are currently detecting respiratory syncytial virus (RSV) infections, ECDC issues rapid scientific advice for policymakers and public health authorities on ways to ...
RSV vaccination in older adults significantly reduced cases of lower respiratory tract disease and deaths, with updated recommendations for high-risk groups. Nirsevimab effectively reduced ...
RSV, or respiratory syncytial virus, is a common illness that causes infections of the breathing passages and lungs. North Carolina's RSV levels are currently classified as "very low," a significant ...